冻干注射剂市场增长、规模、份额、趋势、关键参与者分析及 2028 年预测

  • Report Code : TIPRE00004411
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 200
立即购买

 

冻干注射剂市场规模预计将从 2021 年的 27.1942 亿美元增至 2028 年的 40.0127 亿美元;预计 2022 年至 2028 年的复合年增长率为 5.8%。

推动市场发展的关键因素包括合同研究制造服务需求的增加、药品审批的增加以及生物制剂需求的增加。然而,产品召回抑制了市场的增长。

冻干注射剂是经过冷冻干燥的药物,在运输过程中保持稳定。它们可以存放在一次性小瓶、即时复溶和特殊包装中较长时间。使用时,可借助稀释剂复溶所需数量的药物。冻干注射剂也被称为冻干注射剂,因为它们是通过冻干工艺制造的,冻干工艺是一种通过冷冻和真空蒸发溶液从溶剂中分离固体物质的技术。冻干注射剂通常被认为是口服固体剂型的最佳替代品。在许多案例研究中,注射剂极大地造福了卧床不起的患者。冻干注射剂也用于为患有多种疾病的患者提供最大生物利用度和稳定性,因为这些注射剂的保质期比其他剂型更长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

冻干注射剂市场:

Lyophilized Injectable Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

市场洞察

 

药品审批增加推动市场增长

目前正在开展关于新型冻干治疗剂用于确诊为 COVID-19 的住院成人患者的安全性和有效性的研究。全球冻干注射剂市场的制造商  正在向美国 FDA 申请紧急使用授权 (EUA),以治疗患有严重 COVID-19 症状的患者。

自 COVID-19 疫情爆发以来,全球冻干注射剂市场的参与者正在加大努力,争取获得印度药品管理总局 (DCGI) 等监管机构的批准,以便在印度限制紧急使用。瑞德西韦等药品的批准越来越多,最终导致对冻干注射剂的需求旺盛。以下是 FDA 和其他监管机构批准的几种药品。

  • 2020 年 2 月,迈兰公司获得印度 DCGI 监管部门批准,可在印度使用瑞德西韦冻干粉对 COVID-19 患者进行限制性紧急使用。
  • 2020 年 6 月,西普拉推出了瑞德西韦冻干粉针剂 Cipremi。此外,美国 FDA 还向吉利德科学公司颁发了紧急使用授权 (EUA),允许其紧急使用瑞德西韦治疗住院的 COVID-19 患者。这是 FDA 批准的唯一一种针对疑似或经实验室确诊的 COVID-19 感染住院成人和儿童患者的 EUA 治疗药物。因此,今年 5 月,吉利德科学公司向西普拉提供了一项自愿非独占许可,以生产和销售西普拉的瑞德西韦仿制药 CIPREMI。 
  • 2020 年 7 月,Jubilant Life 获得印度药品管理总局 (DCGI) 的批准,在印度生产和销售 100 毫克/瓶(冻干注射剂)的瑞德西韦,供限制性紧急使用,用于治疗重症 COVID-19。
  • 2020年8月,诺华公司的Cosentyx一次性使用冻干粉获得欧盟批准。该药物在快速改善皮肤症状和提高牛皮癣患者的生活质量方面非常有效。 

因此,全球范围内日益增多的批准推动了冻干注射剂市场的增长。

 

基于包装类型的见解

根据包装类型,全球冻干注射剂市场分为一次性小瓶、即时复溶和特种包装。2021 年,一次性小瓶细分市场占据最大市场份额,而特种包装细分市场预计在预测期内将实现最高复合年增长率,为 6.7%。

 

基于交付类型的洞察

根据给药类型,全球冻干注射剂市场细分为预充式稀释剂注射器、专有重构设备、单步设备和多步设备。预充式稀释剂注射器细分市场在 2021 年占据最大市场份额,预计在预测期内将录得最高复合年增长率 6.3%。

 

基于指示的见解

根据适应症,全球冻干注射剂市场细分为代谢和肿瘤疾病、传染病、自身免疫性疾病和其他适应症。代谢和肿瘤疾病领域在 2021 年占据最大市场份额,预计在预测期内将录得最高复合年增长率 6.2%。

 

基于最终用户的洞察     

根据最终用户,全球冻干注射剂市场分为医院、门诊手术中心、专科诊所和其他。医院部门在 2021 年占据了最大的市场份额。然而,预计专科诊所部门在预测期内的复合年增长率最高,为 6.3%。

在全球冻干注射剂市场运营的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。例如,2022 年 4 月,Recipharm 收购了先进疗法 CDMO Arranta Bio 和病毒疗法 CDMO Vibalogics。此次收购还使 Recipharm 能够在美国建立强大的基地,在马萨诸塞州 Boxborough 设有工厂,并提供了一个平台来建立其在新生物制剂模式方面的能力。

 

 

冻干注射剂市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响冻干注射剂市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的冻干注射剂市场细分和地理位置。

Lyophilized Injectable Market
  • 获取冻干注射剂市场的区域特定数据

冻干注射剂市场报告范围

报告属性细节
2021 年市场规模27.2亿美元
2028 年市场规模40亿美元
全球复合年增长率(2021 - 2028)5.8%
史料2019-2020
预测期2022-2028
涵盖的领域按包装类型
  • 一次性使用小瓶
  • 即时重构
  • 特殊包装
按交付类型
  • 预充式稀释剂注射器
  • 单步设备
  • 专有重构设备
  • 多步骤设备
按适应症
  • 代谢和肿瘤状况
  • 传染病
  • 自身免疫性疾病
按最终用户
  • 医院
  • 门诊手术中心
  • 专科诊所
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 巴克斯特
  • 尼普罗
  • Curia Global, Inc.
  • 瑞必康公司
  • 维特制药公司
  • Jubilant HollisterStier LLC(Jubilant Pharma Limited)
  • 阿里斯托制药有限公司
  • 科登制药国际公司
  • Credence MedSystems, Inc.

 

冻干注射剂市场参与者密度:了解其对业务动态的影响

冻干注射剂市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在冻干注射剂市场运营的主要公司有:

  1. 巴克斯特
  2. 尼普罗
  3. Curia Global, Inc.
  4. 瑞必康公司
  5. 维特制药公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Lyophilized Injectable Market

 

  • 获取冻干注射剂市场顶级关键参与者概览

 

 

全球冻干注射剂市场 – 按地区划分

从地理上看,全球冻干注射剂市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、英国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、印度、日本、韩国、澳大利亚和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

公司简介

  • 巴克斯特
  • 尼普罗
  • Curia Global, Inc.
  • 瑞必康公司
  • 维特制药公司
  • Jubilant HollisterStier LLC(Jubilant Pharma Limited)
  • 阿里斯托制药有限公司
  • 科登制药国际公司
  • Credence MedSystems, Inc.
  • SG Biopharm 私人有限公司
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
lyophilized-injectable-drugs-market-report-deliverables-img1
lyophilized-injectable-drugs-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What is the regional market scenario of the lyophilized injectable market?

Global lyophilized injectable market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for lyophilized injectable market. The growth of the market in North America is expected due to the factors such as increasing demand for lyophilized injectable for safer packaging and prolonged shelf life, growing pharmaceutical production due to pandemic, and rising research and development in the healthcare industry. Further, the growing research & development activities owing to the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and the rise in the research & applications of the lyophilized injectable drug in various fields are the key factors responsible for the Asia-Pacific regional growth for lyophilized injectable accounting for the fastest growth of the region during the coming years.

Who are the key players in the lyophilized injectable market?

Baxter, Nipro, Curia Global, Inc., Recipharm AB, Vetter Pharma, Jubilant HollisterStier (Jubilant Pharma Limited), Aristopharma Ltd., CordenPharma International, Credence MedSystems, Inc., and S. G. Biopharm Pvt. Ltd. are among the leading companies operating in the lyophilized injectable market.

Which end user segment led the lyophilized injectable market?

Based on end user, hospital segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which indication segment held the largest market share in the lyophilized injectable market?

The metabolic and oncology conditions segment dominated the indication segment in the global lyophilized injectable market and accounted for the largest market share of 46.05% in 2021.

Which type of delivery segment led the lyophilized injectable market?

Based on type of delivery, prefilled diluent syringes segment accounted for the largest share in 2021 in the worldwide market and is expected to continue to do so till the forecast period.

What is meant by the lyophilized injectable market?

Lyophilized injectables are freeze-dried drugs that are more stable and can be transported and stored for a longer period. At the time of use, the required quantity of drugs can be reconstituted with the help of diluents. Lyophilized injectable are also termed as freeze-dried injectable as they are produced by the lyophilization process which is the technique of isolating a solid material from a solvent by freezing and evaporating the solution under vacuum. The lyophilized injectable market is segmented into type of packaging, type of delivery, indication, end user, and geography.

What are the driving factors for the lyophilized injectable market across the globe?

Increasing demand of contract research manufacturing services and rising approvals of pharmaceuticals are the most significant factors responsible for the overall market growth.

Which type of packaging segment held the largest market share in the lyophilized injectable market?

Based on type of packaging, single-use vials segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Lyophilized Injectable Drugs Market

  1. Baxter
  2. Nipro
  3. Curia Global, Inc.
  4. Recipharm AB
  5. Vetter Pharma
  6. Jubilant HollisterStier LLC (Jubilant Pharma Limited)
  7. Aristopharma Ltd.
  8. CordenPharma International
  9. Credence MedSystems, Inc.
  10. S. G. Biopharm Pvt. Ltd
lyophilized-injectable-drugs-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.